Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Pharmacist And Pillpack Intervention

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT04717297Not ApplicableCompletedPrimary

Tailored Medication Management Intervention

NCT04376112Not ApplicableWithdrawn

Influence of Pharmacist and Student Pharmacists on Medication Adherence in Community Pharmacy Setting in Underserved Population

NCT03408873Phase 4Completed

CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

Showing all 3 trials

Research Network

Common Treatments

  • Pharmacist And Pillpack Intervention1
  • Abilify Maintena1
  • Standard Of Care1
  • Medication Management Inperson Intervention1
  • Waitlist Control1

Active Sponsors

  • Otsuka Pharmaceutical Development & Commercialization, Inc.1
  • Martha Sajatovic1
  • Loma Linda University1
  • Washington University School of Medicine1

Top Investigators

Related Conditions

  • Bipolar Disorder1
  • Polypharmacy1
  • Medication Adherence1
  • Pharmacistpatient Relations1
  • Blood Pressure1

Activity Timeline